The findings in the PBMC of patients with a monoallelic point mutation in SNRNP200 established a deregulation of innate immunity, which may affect cell viability in different retinal disorders, as these cells and neural cells are usually non-proliferative and long-lived. The gene discussed is SNRNP200; the disease is retinal disorder.